ACC 2017: Double-Whammy Trial Data Boost For Philips' iFR

Results from the iFR SWEDEHEART and DEFINE-FLAIR trials, both presented at this month's American College of Cardiology Scientific Sessions in Washington, DC, show that coronary revascularization guided by instantaneous wave-free ratio measurement is non-inferior to fractional flow reserve measurement in guiding coronary revascularization

coronary artery plaque 3d illustration
Coronary Artery Plaque • Source: Source: Shutterstock

Philips Volcano's iFR (instantaneous wave-free ratio) is non-inferior to fractional flow reserve as a tool for guiding coronary revascularization, according to the results of two separate clinical trials totaling 4,529 patients.

iFR is Philips Volcano’s proprietary technology for measuring the differential across a coronary lesion with a pressure-wire during the wave-free period of the heartbeat. It can assess lesion significance in...

More from Cardiology

More from Device Area